Brooklyn Investment Group
ARCT icon

Brooklyn Investment Group’s Arcturus Therapeutics ARCT Stock Holding History

Brooklyn Investment Group’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,441
Closed -$18.7K – 789
2025
Q2 		$18.7K Buy
1,441
+1,404
+3,795% +$16.6K ﹤0.01% 1856
2025
Q1 		$392 Sell
37
-251
-87% -$3.98K ﹤0.01% 2535
2024
Q4 		$4.89K Buy
+288
New +$5.42K ﹤0.01% 1217

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Schonfeld Strategic Advisors
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Brooklyn Investment Group's ARCT Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Arcturus Therapeutics (ARCT) in Q3 2025, closing a stake of 1,441 shares — an estimated $18.7K sold.

Brooklyn Investment Group first reported a position in ARCT in Q4 2024 and held it in 3 quarters. The position peaked at $18.7K in Q2 2025. 137 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Arcturus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 1,441 Arcturus Therapeutics shares in Q3 2025, an estimated $18.7K.
  • Brooklyn Investment Group first reported a position in Arcturus Therapeutics in Q4 2024 and held it in 3 quarters.
  • Brooklyn Investment Group's Arcturus Therapeutics position peaked at $18.7K in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.